Stock kasuwa, musayar ciniki a yau
Rahoton samfurori na kamfanonin 71229 a ainihin lokacin.
Stock kasuwa, musayar ciniki a yau

Rahoton samfurori

Stock ya faɗi a kan layi

Stock ya faɗi tarihi

Kasashen kasuwancin jari

Stock dividends

Riba daga kamfanin kamfanoni

Rahotan kuɗi

Ƙididdiga na kamfanoni. A ina zan zuba kudi?

Eidos Therapeutics, Inc. albashi ta raba

Rahoton kuɗi na kamfanin Eidos Therapeutics, Inc., ya bayar da rahoto game da ribar da aka samu na EIDX a shekarar 2024. Yaushe Eidos Therapeutics, Inc. ya buga rahotanni na kudi kan riba da asarar?
Ƙara zuwa widget din
Ƙara zuwa widget din

Yaushe Eidos Therapeutics, Inc. ya wallafa wata sanarwa da asara?

Rahotanni na Eidos Therapeutics, Inc. da kuma asarar da aka wallafa sau ɗaya a cikin kwata, an wallafa asusun ajiyar kuɗi na Eidos Therapeutics, Inc. a ranar 30/09/2019.

Mene ne riba daga hannun jari na Eidos Therapeutics, Inc.?

Abinda aka kiyasta ta hannun Eidos Therapeutics, Inc. ya kasance 0.18 $ a cikin rahoton kudi na ƙarshe.

Yaushe Eidos Therapeutics, Inc. zai buga bayanan asara da asarar gaba?

Rahoton na gaba akan asusun riba da asarar Eidos Therapeutics, Inc. zai kasance ranar Disamba 2024.

Eidos Therapeutics, Inc. albashin da kaso na kungiyar hada-hadar kudade ke lissafa ne na nasarar kamfanin, wanda aka jingina da kimar kungiyar kansa. Ana tara albashin da kashi ɗaya cikin sauki - duk ribar kamfanin don rahoton hada-hadar kuɗi ya raba ta hannun adadin hannun jari. Eidos Therapeutics, Inc. ana tara albashi ta kowane bangare akan kowane tazara na kudi. Riba na Eidos Therapeutics, Inc. - jimlar riba na lokacin hada-hadar kudi.

Nuna:
To

Riba Eidos Therapeutics, Inc.

Riba ga kamfanin gaba daya Eidos Therapeutics, Inc. ya fi mahimmanci ga masu gudanarwa fiye da masu hannun jarin kamfanin. Mafi nuna alama mai ban sha'awa ita ce riba ta kowace kashi, wanda kai tsaye ke rinjayar adadin rabon kowane rabo. Ranan rahoton ribar Eidos Therapeutics, Inc. ya danganta da dokar ƙasar ta rijistar kamfanin. Kowace ranar Eidos Therapeutics, Inc. Bayanin riba ya dace da layi a cikin teburin sabis.

Bincike na hamsin Eidos Therapeutics, Inc.

Abubuwan da suka samu ta hanyar Eidos Therapeutics, Inc. an ƙididdige ta hanyar raba kudin shiga da adadin hannun jari a kamfanin. Samun kuɗi ta hanyar rarrabuwa Eidos Therapeutics, Inc. alama ce ta wani tsaka tsakin kuɗi. Abu ne mai sauki ka iya tunanin cewa lokacin hada-hadar kudi ya zo daidai da batun bayyana bayanan asusun riba. Eidos Therapeutics, Inc. albashin da ya samu kaso na mafi karancin lokaci yana kan jadawalin a saman shafin. Riba kwata-kwata Eidos Therapeutics, Inc. shine babban nau'in bayanan hada-hadar kudi tsakanin kamfanoni.

EIDX rahoton kwanan wata Raba ta kashi
Ana kiyasta yawan kuɗin da aka raba ta hanyar rarraba kudaden shiga (ko riba) ta yawan adadin kamfanonin kamfanin.
Canja don shekara %
30/09/2019 0.18 USD -8.89% ↓
30/06/2019 -0.39 USD -41.88% ↓
31/03/2019 -0.32 USD -
31/12/2018 -0.27 USD -
30/09/2018 -0.29 USD -
30/06/2018 -1.38 USD -

Eidos Therapeutics, Inc. Albashin da ya samu na kwata-kwata a kashi ɗaya wani kaso ne na ribar kamfanin. Amma an kasa buƙata fiye da riba na shekara akan rabon ɗaya. Profitarshen kwata-kwata Eidos Therapeutics, Inc. yanzu ana ɗaukar shi a matsayin ribar kwata-kwata ƙarshen ƙulli na ƙarshen wannan shekarar. Canjin ribar Eidos Therapeutics, Inc. na shekara an lissafta shi ne idan aka kwatanta da irin lokacin kuɗin da aka yi daidai da mai nuna halin yanzu kawai na shekarar da ta gabata. Canjin kashi ɗaya bisa ɗari na Eidos Therapeutics, Inc. ƙarancin ƙima darajar dangane da canjin ribar shekara-shekara na Eidos Therapeutics, Inc..

An nuna alamun ƙarfafa ribar kamfanin a matsayin kashi. Tarihin ribar Eidos Therapeutics, Inc. na shekarun da suka gabata an ba mu a cikin teburinmu "Ribar kwata-kwata". Eidos Therapeutics, Inc. Tarihin samun kudaden shiga kwata-kwata wanda aka gani akan layi cikin shekaru goma da suka gabata. Ba a tattara bayanan tarin riba na shekarar da ta gabata da sauran lokutan Eidos Therapeutics, Inc. daga hanyoyin jama'a.

Kudin hannun jari Eidos Therapeutics, Inc.

Finance Eidos Therapeutics, Inc.